Related Experiment Video
Updated: Aug 19, 2025

A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
Racial bias in recruitment to clinical trials on paediatric asthma
Adam Lawton1, Alexander Stephenson-Allen2, Abigail Whitehouse3
1North Middlesex NHS Hospital Trust, United Kingdom.
Insights
Clinical trials for pediatric asthma lack diversity. White children are overrepresented, while non-white children are underrepresented in asthma research, impacting treatment equity.
Area of Science:
- Pediatric pulmonology
- Clinical trial diversity
- Health equity in childhood asthma
Background:
- Asthma is the most common chronic childhood illness.
- Disparities in medical care affect pediatric asthma outcomes.
- Representation in clinical trials is crucial for equitable treatment.
Purpose of the Study:
- To assess the ethnic diversity of participants in pediatric asthma clinical trials.
- To identify the proportion of white and non-white children in asthma research over the last decade.
Main Methods:
- Searched ClinicalTrials.gov for completed interventional pediatric asthma studies (2011-2021).
- Analyzed demographic data for race and ethnicity of study participants.
- Calculated the percentage of white and non-white children in the analyzed trials.
Main Results:
- Of 112,327 patients across 208 studies, 69% were identified as White/Caucasian.
- Fewer than 13% of participants were identified as Black/African/African-American.
- Approximately 30% of study participants, totaling 34,207 children, were from non-white backgrounds.
Conclusions:
- Significant underrepresentation of non-white children in pediatric asthma clinical trials was observed.
- Researchers must prioritize representative populations in trial design.
- Ensuring diversity in clinical trials is essential for equitable asthma treatment and outcomes.
Abstract:
Asthma is now the commonest chronic disease of childhood, but not all children with asthma receive equivalent standards of medical care which influences their clinical outcomes. In this paper we sought to determine the proportion of participants in registered clinical trials relating to paediatric or adolescent asthma over the last decade that were from white and non-white backgrounds. We searched the ClinicalTrials.gov database for all completed interventional studies between the dates 1st January 2011 and 1st January 2021 that were on the topic of 'asthma', and included participants below 18 years of age. Of the 500 studies returned, 208 had results available on the ClinicalTrials.gov website. In total, of the 112,327 patients studied, almost 69 % (77,333) of the patients were described as White or Caucasian, and fewer than 13 % (14,189) were described as Black, African, or African-American. Overall, approximately 30 % of study participants - some 34,207 children - were from non-white backgrounds. To redress this imbalance, researchers designing clinical trials must ensure that their study populations are as representative of the target population for the intervention as possible.
Related Concept Videos
Bias in Epidemiological Studies
Blinding
Bias
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Trials: Overview

